Opportunity ID: 337186

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-MH-22-170
Funding Opportunity Title: Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.242 — Mental Health Research Grants
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 03, 2022
Last Updated Date: Jan 03, 2022
Original Closing Date for Applications: May 10, 2022
Current Closing Date for Applications: May 10, 2022
Archive Date: Jun 15, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Special district governments
Public and State controlled institutions of higher education
County governments
City or township governments
Small businesses
State governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Private institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: Efforts are underway to develop a safe and effective vaccine to protect people from acquiring HIV ultimately reducing the number of new infections and ending the epidemic. However, the subject of vaccines remains contentious, and COVID-19 has heightened the conversation. There are multiple messages circulating both for and against vaccines and a growing number of skeptics appear to be making decisions about vaccines based on misinformation. This initiative will advance research on communication factors and strategies that will be crucial for successful public understanding, acceptance, and uptake of future vaccines that protect against HIV.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-170.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Folder 337186 Full Announcement-RFA-MH-22-170 -> RFA-MH-22-170-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00271193 Apr 10, 2022 May 10, 2022 View

Package 1

Mandatory forms

337186 RR_SF424_5_0-5.0.pdf

337186 PHS398_CoverPageSupplement_5_0-5.0.pdf

337186 RR_OtherProjectInfo_1_4-1.4.pdf

337186 PerformanceSite_4_0-4.0.pdf

337186 RR_KeyPersonExpanded_4_0-4.0.pdf

337186 PHS398_ResearchPlan_4_0-4.0.pdf

337186 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

337186 RR_Budget_3_0-3.0.pdf

337186 RR_SubawardBudget30_3_0-3.0.pdf

337186 PHS398_ModularBudget_1_2-1.2.pdf

337186 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T08:54:25-05:00

Share This Post, Choose Your Platform!

About the Author: